STAT+: Telemedicine company touted by Novo Nordisk stressed profits over patient safety, ex-workers say

Novo Nordisk promotes LifeMD as a provider for GLP-1 drugs, but former employees allege the telehealth company prioritized profits over patient safety by pressuring providers to rapidly issue prescriptions without thorough clinical review. Ex-workers reported providers were sometimes required to process 25 patient cases per hour, with limited time spent per case and discouragement of medically relevant questions.